VolitionRX Ltd (VNRX) Stock Ticker
VNRX right now
Market factors today
Unlock the full VNRX picture
About VolitionRX Ltd
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
VNRX stock facts
| Ticker symbol | VNRX |
| Exchange | New York Stock Exchange Arca |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $2.2M |
| CEO | Cameron Reynolds |
| Employees | 57 |
| Headquarters | Henderson, NV, US |
| IPO date | 2012-03-02 |
| Website | volition.com |
What you can see for VNRX on Tickr
Live VNRX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the VNRX report.
Rankings
FAQ
What is the ticker symbol for VolitionRX Ltd?
The ticker symbol for VolitionRX Ltd is VNRX, listed on the New York Stock Exchange Arca.
What is VNRX?
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling…